Leadership

Precision-Panc was established in 2017 as a research collaboration with the majority of funding coming from Cancer Research UK (CRUK). It is led by Prof. Andrew Biankin, Professor David Chang (University of Glasgow), Prof. Owen Sansom (Cancer Research UK Beatson Institute), Prof. Jeff Evans (Cancer Research UK Glasgow Clinical Trials Unit), Professor Caroline Dive (University of Manchester), Professor Chris Lord (ICR), Professor Duncan Jodrell (CRUK institute Cambridge), Professor Eric O’Neil (University of Oxford) as joint lead investigators, as well as a Steering Committee.

For a complete list of grantholders, investigators and committee members, visit Meet The Team.  

Steering Committee

The Steering Committee is comprised of grantholders, investigators, a patient representative, and a representative of CRUK. Additional collaborators, including a representative of the US-based Precision Promise initiative, are also invited to participate.

Its remit is to: 

• Provide oversight of the Precision-Panc Programme, track its progress and take steps to keep it on course for completion on time and within budget;
• Agree mechanisms for project management and progress reporting;
• Agree indicators of success;
• Provide a forum for project management and issue resolution, as well as risk and incident management;
• Ensure that appropriate ethics approvals and consents are obtained for the purposes of the funded work;
• Actively seek and identify opportunities for publishing results, make recommendations to Investigators who may wish to prepare publications of results, and support the drafting and preparation of publications of results in accordance with the Cancer Research UK Grant Conditions

Scientific Advisory Board

The Scientific Advisory Board is comprised of eight external scientific experts who have distinguished themselves in the area of cancer genetics/genomics/clinical trials, in addition to at least one patient advocate. Through annual meetings, the group will advise and guide the project throughout its lifetime. 

Its remit is to:

• Provide insight into the quality of the project deliverables and the scientific, technical and methodological progress of the project;
• Advise on the plans for dissemination, international discussion and promotion of the project and its associated results.

Umbrella Trials Steering Committee

The Umbrella Trial Steering Committee is run through the CRUK Clinical Trials Unit Glasgow to oversee all Precision-Panc trials run at the Glasgow Clinical Trials Unit.  

Precision-Panc Patient Advisory Group

The Precision-Panc Patient Advisory Group is a group of patient and carers identified via Pancreatic Cancer UK’s Research Involvement Network and Cancer Research UK’s Your Involvement Network to provide insight and guidance into our research efforts.

Its remit is to:

• Review and develop key message documents for both patients and healthcare professionals; 
• Review the Precision-Panc website and provide suggestions for updates;
• Participate on the Precision-Panc Steering Committee, Scientific Advisory Board and Umbrella Trials Steering Committee;
• Provide consultations for Precision-Panc researchers including reviewing patient facing material such as the patient information sheets as well as ensuring all protocol investigations required by a study would be acceptable to patients.

External Networks

Precision-Panc is also represented throughout the pancreatic cancer network, both in the UK and abroad, including:

• NHS England
• NHS Scotland
• Cancer Research UK Glasgow Clinical Trials Unit:
• Pancreatic Cancer UK
• Pancreatic Cancer Scotland
• Pancreatic Cancer Action
• World Pancreatic Cancer Coalition
• Pancreatic Cancer Research Fund
• NCRI Upper Gastrointestinal Group & Pancreatic Subgroup
• International Cancer Genome Consortium ARGO
• Pancreatic Cancer Action Network’s Precision Promise programme